Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Healthcare Industry News Zydus Lifesciences to commercialize OncoStem’s CanAssist Breast test Zydus Lifesciences has secured exclusive marketing rights to CanAssist Breast, a prognostic test for breast cancer patients in… byPallavi MadhirajuNovember 16, 2022